Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 5, 2009, Pages 800-805

  Lee, Jeong Ok ^a   Kim, Dae Young ^a   Lim, Joo Han ^a   Seo, Myung Deok ^a   Yi, Hyeon Gyu ^a   Oh, Do Youn ^a,b   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Chemotherapy; Hepatocellular carcinoma; Liver transplantation; Recurrence

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CAPECITABINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; INTERFERON; MITOMYCIN; OXALIPLATIN; SORAFENIB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 65949103437     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05672.x     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005 55 : 74 108. (Pubitemid 40372904)
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003 362 : 1907 17. (Pubitemid 37518510)
3. Rougier P, Mitry E, Barbare JC, Taieb J. Hepatocellular carcinoma (HCC): an update. Semin. Oncol. 2007 34 : S12 20. (Pubitemid 46590363)
4. Qiu J, Ozawa M, Terasaki PI. Liver transplantation in the United States. Clin. Transplant. 2005 17 28.
5. Middleton PF, Duffield M, Lynch SV et al. Living donor liver transplantation-adult donor outcomes: a systematic review. Liver Transpl. 2006 12 : 24 30.
6. Morioka D, Egawa H, Kasahara M et al. Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann. Surg. 2007 245 : 315 25. (Pubitemid 46148492)
7. Nadalin S, Malago M, Radtke A et al. Current trends in live liver donation. Transpl. Int. 2007 20 : 312 30. (Pubitemid 46310630)
8. de Villa VH, Lo CM, Chen CL. Ethics and rationale of living-donor liver transplantation in Asia. Transplantation 2003 75 : S2 5. (Pubitemid 36222978)
9. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996 334 : 693 9. (Pubitemid 26079803)
10. Roayaie S, Schwartz JD, Sung MW et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004 10 : 534 40. (Pubitemid 38443593)
11. Regalia E, Fassati LR, Valente U et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat. Surg. 1998 5 : 29 34. (Pubitemid 128662554)
12. Kim YS, Lim HK, Rhim H, Lee WJ, Joh JW, Park CK. Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. AJR Am. J. Roentgenol. 2007 189 : 352 8. (Pubitemid 47195920)
13. Schlitt HJ, Neipp M, Weimann A et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J. Clin. Oncol. 1999 17 : 324 31. (Pubitemid 29022410)
14. Ferris JV, Baron RL, Marsh JW et al. Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology 1996 198 : 233 8. (Pubitemid 26008270)
15. Jonas S, Bechstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001 33 : 1080 6. (Pubitemid 32378206)
16. Tamura S, Kato T, Berho M et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch. Surg. 2001 136 : 25 30. discussion 1. (Pubitemid 32064116)
17. Vivarelli M, Bellusci R, Cucchetti A et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 2002 74 : 1746 51. (Pubitemid 36019329)
18. Stippel DL, Kasper HU, Schleimer K et al. Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation. Transplant. Proc. 2005 37 : 2185 7. (Pubitemid 40956407)
19. Schwartz M, Roayaie S, Llovet J. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J. Hepatol. 2005 43 : 584 9. (Pubitemid 41253224)
20. Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002 359 : 1734 9. (Pubitemid 34607087)
21. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35 : 1164 71. (Pubitemid 34454013)
22. Kogure T, Ueno Y, Iwasaki T, Shimosegawa T. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors. Cancer Chemother. Pharmacol. 2004 53 : 296 304. (Pubitemid 38392354)
23. Abou-Alfa GK, Schwartz L, Ricci S et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J. Clin. Oncol. 2006 24 : 4293 300. (Pubitemid 46630787)
24. Louafi S, Boige V, Ducreux M et al. Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study. Cancer 2007 109 : 1384 90. (Pubitemid 46466566)
25. Boige V, Raoul JL, Pignon JP et al. Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial. Br. J. Cancer 2007 97 : 862 7. (Pubitemid 47519302)
26. Ikeda M, Okusaka T, Ueno H, Takezako Y, Morizane C. A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma. Cancer 2005 103 : 756 62. (Pubitemid 40216404)
27. Yeo W, Mok TS, Zee B et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J. Natl Cancer Inst. 2005 97 : 1532 8. (Pubitemid 41631953)
28. Park SH, Lee Y, Han SH et al. Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma. BMC Cancer 2006 6 : 3 8. (Pubitemid 43078827)
29. Llovet JM, Ricci S, Mazzaferro V et al. Sorafenib in advanced hepatocellular carcinoma (HCC): results of a phase III randomized placebo-controlled trial (SHARP trial). New Engl. J. Med. 2008 359 : 378 90.
30. Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991 68 : 2095 100.
31. Kneteman NM, Oberholzer J, Al Saghier M et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl. 2004 10 : 1301 11. (Pubitemid 39406087)
32. Zimmerman MA, Trotter JF, Wachs M et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl. 2008 14 : 633 8.
33. Kornberg A, Kupper B, Tannapfel A et al. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results. Transpl. Int. 2008 21 : 96 9. (Pubitemid 350198289)